Researchers from a Boston hospital detailed the results of a five-year study, showing that a Sanofi drug which helps moderate glucose levels in those with type II diabetes, did not increase the risk of a cardiovascular event. Marc Pfeffer, Victor J. Dzau Professor of Medicine at Brigham and Women’s Hospital, is principal investigator of the study.
Trending News
Medicare Spending Rises After Private Equity Buys Hospices
Longer stays suggest a shift toward patients who need less daily care
New Harvard Medical School Co-Director of Harvard-MIT Program in Health Sciences and Technology Welcomed
David Hirsh brings expertise in medical education innovation, deep-rooted humanism
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?